|
Wednesday, September 1
|
Roger A. Greenberg, MD, PhD
|
Synthetic Lethality in Cancer
|
Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors
Clinical Supplement
Supplementary Reading
|
|
Wednesday, September 8
|
David C. Fajgenbaum, MD, MBA, MSc
|
The Hyperinflammatory Debate in COVID19 and Therapeutic Implications
|
Global absence and targeting of protective immune states in severe COVID-19
Clinical Supplement
|
|
Monday, September 20
|
Drew Weissman, MD, PhD
|
A ‘Universal’ Coronavirus Vaccine
|
Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
Clinical Supplement I
Clinical Supplement II
|
|
Monday, September 27
|
Sara Rendell, PhD
|
Heroin and Social Divides
|
The Textures of Heroin: User Perspectives on “Black Tar” and Powder Heroin in Two US Cities
Clinical Supplement
Supplemental Reading I
Supplemental Reading II
|
|
Monday, October 4
|
Mark Sellmyer, MD, PhD
|
See-ing Bacteria |
Imaging Enterobacterales infections in patients using pathogen-specific positron emission tomography
Clinical Supplement
|
|
Friday, October 8
|
Kathryn Davis, MD, M.S.T.R.
|
Translating Network Statistics to the Bedside in the Treatment of Drug-Resistant Epilepsy
|
Structural Brain Network Abnormalities and the Probability of Seizure Recurrence After Epilepsy Surgery
Clinical Supplement
|
|
Monday, October 18
|
Marie Guerraty, MD, PhD
|
The Black Box of HFpEF |
Nitrosative stress drives heart failure with preserved ejection fraction
Clinical Supplement
|
|
Monday, October 25
|
William Peranteau, MD
|
Therapeutic Genome Editing |
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates
Clinical Supplement
|
|
Friday, November 5
|
Xilma Ortiz-Gonzalez, MD, PhD
|
A Precision Medicine Therapeutic |
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
Clinical Supplement
Supplemental Reading I
|
|
Monday, November 15
|
Rajan Jain, MD
Rahul Kohli, MD, PhD
|
Mentor-Mentee Relationships |
|
|
Monday, November 29
|
Jennifer L. Orthman-Murphy, MD, PhD
|
The Challenges to Developing Reparative Therapy for Multiple Sclerosis |
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis
Clinical Supplement
Supplementary Reading
|
|
Friday, December 10
|
Audrey Odom John, MD, PhD
|
The Mechanistic Basis for Multisystem Inflammatory Syndrome in COVID19 |
Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation
Clinical Supplement
Supplemental Reading I
Supplemental Reading II
|
